Subsequent Events

12 Months Ended

Dec. 31, 2012

Subsequent Events [Abstract]

Subsequent Events

14. Subsequent Events

To date in the first quarter of 2013, the Company has sold approximately $350,000 to accredited investors in exchange for shares of the Company’s common stock pursuant to a private placement. The private placement has been amended to remain open until the end of the first quarter 2013.

The Company believes that it will sell a significant amount of common stock in the first quarter of 2013 prior to the closing of the private placement.

In the first quarter of 2013, the Company entered into a supply agreement with its drug product manufacturer for the manufacture of the Company’s drug product for delivery in May of 2013. The agreement calls for the Company to pay approximately $150,000 in various stages until the final drug product is manufactured, successfully tested and delivered to the Company.